Keeping Track: An RMAT, Two QIDPs, And Some Bad News Too

The latest drug development news and highlights from our FDA Performance Tracker.

Keeping Track Feature image

It was a busy week in the innovation arena, with several companies announcing the use of an expedited pathway.

Kiadis Pharma N.V. garnered a Regenerative Medicine Advanced Therapy (RMAT) designation for its ATIR101, highlighting the popularity of the RMAT...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet